Fantasy football has been part of HemoShear's culture for 12 years. In support of Damar Hamlin, we have donated this season's $1,350 prize money to his Chasing M's Foundation. #DamarHamlinStrong#ShearOn3!
Patients like Emma inspire us every day as we work hard to develop HST5040 for methylmalonic and propionic acidemias. Read her amazing story #ShearOn https://t.co/mTIwZFdlqK
This holiday season, we are proud to support Charlottesville's ReadyKids, an organization that provides local counseling, family support and early learning. #ShearOn!
Members of our management team will attend the Piper Sandler Healthcare Conference. Meetings with our team can be requested through Piper Sandler. https://t.co/N9hXxRl7iP
HemoShear was founded on scientific innovation developed at the University of Virginia. Many of us graduated from and have worked at this incredible university. Our hearts go out to the UVA families and community affected by this senseless tragedy. #UVA
Our team of more than 30 scientists is making rapid progress in identifying drug targets and potential candidates to treat rare diseases with high unmet medical need. Read about our REVEAL-Tx advantage! https://t.co/7v9YHnztOj
We are advancing potential lead product candidates against a second target for @HorizonNews. This is our fith collaboration milestone to discover new therapies for painful #gout! https://t.co/uTx0h1AnGu
We are thrilled to announce that our co-founder @brian_wamhoff has been appointed interim CEO of HemoShear. Brian has been an inspiration, relentless patient advocate and scientific visionary since our inception. #rarediseases#ShearOn! https://t.co/adBkA9g1nV
Congratulations to Dr. M. Sol Collado and our discovery biology team for developing a new human tissue-based model of a rare #liverdisease through our collaboration with @TakedaPharma. We plan to assess therapeutic approaches for a challenging liver disease with high unmet need.
Carina is an Ambassador for AllStripesβ methylmalonic acidemia (MMA) research program. We are jumpstarting our MMA program to accelerate research on the disease to ultimately improve treatment options. To learn more, head to https://t.co/FWDxx6nfM8
Four years ago we attended the @OrganicAcidemia family conference. We met with a group of parents to learn about their experience managing MMA and PA. They shared their challenges, worries and joys. These insights motivate us in our mission to improve quality of life for families
Thank you @DNApodcast and Bryan @BepresentS11 for the opportunity to discuss the impact of MMA and PA on patients and our clinical trial to assess our potential new treatment
Patient advocate, Bryan Kelly (@BepresentS11), & @HemoShear CMO, Dr. Pat Horn, discuss life with Proprionic and Methylmalonic Acidemia & potential treatments! ππ
#PA#MMA#metabolicdisorders
πListen here: https://t.co/4Axyh0mPHJ
We are excited to have a poster on our JUMP natural history study presented at the Genetic Metabolic Dietitian conference. The @_allstripes platform provides secure access to patients'medical records to gather data on #rarediseases https://t.co/E1xHoHCUDE